About Us Attorney Bios Testimonials & Verdicts Referrals Firm News Contact Us Home Harmful Drug Side Effects Defective Medical Devices Unsafe Consumer Products Ohio Personal Injury About Us Contact Us More NuvaRing Lawsuit Filed by Wright & Schulte Seeks Compensation for Plaintiff’s Life-Threatening Blood Clot Disorders Allegedly Caused by NuvaRing Use

Image of vaginal birth control device NuvaRing

Image of vaginal birth control device NuvaRing (Photo credit: Wikipedia)

My firm is currently representing a woman from Cape Coral, Florida in recently filed a NuvaRing lawsuit
(Case No. 2:13-cv-00721-SPC-DNF). This case, which was filed on October
11, 2013 in the U.S. District Court of Ohio, contends that the
plaintiff developed serious blood clotting disorders as a direct result
of using NuvaRing. Additionall, court documents for this case charge
that the defendants, Organon USA, Inc. and Merck & Co., Inc.,
marketed NuvaRing as a safe and effective form of contraception despite
knowing about the serious side effects linked to it.

Wright & Schulte, LLC focuses on defending the rights of those
who have sustained serious injuries after using dangerous medications
and defective medical devices.
Our skilled NuvaRing attorneys are experienced at successfully going up
against large corporations. We encourage those who believe that they
have been injured due to the use of NuvaRing to speak with our
knowledgeable NuvaRing lawyers by visiting yourlegalhelp.com or by
calling 1-800-399-0795.

According to court documents, the plaintiff started using NuvaRing in
January 2011 when she was 22 years old. Within a month, the plaintiff
reportedly started to experience severe pain in her right leg and sought
medical care for an official diagnosis. At that time, the plaintiff
underwent an ultrasound and was, subsequently, informed that she had
developed deep vein thrombosis (DVT) in her right leg. Although the
plaintiff was prescribed Coumadin for six months, by August 2011, the
severe pain in her right leg erupted once again.

Upon seeking medical attention, the plaintiff was told that she still
had DVT in her right leg and that she had also developed pulmonary
embolism, a life-threatening condition in which blood clots lodge in the
lung’s airways. While the plaintiff was hospitalized to treat her
pulmonary embolism, she was also placed on anticoagulation therapy that
included Lovenox, Coumadin and Warfarin. In the aftermath of her
hospitalization, the plaintiff has had to continue anticoagulation
therapy and attend regular follow-up doctor’s appointments to monitor
her health.

Enhanced by Zemanta

Add Comment